Sep 22, 2020

First-in-human trial of new MedTech to support critically ill newborns.

First-in-human trial of new MedTech to support critically ill newborns.

MedTech Actuator startup Navi Medical Technologies passed a major milestone recently when the clinical prototype of the Neonav ECG Tip Location System was used on patients for the first time.

The Neonav is being developed to deliver life-saving drugs and nutrients to critically ill newborns. The commencement of the ‘feasibility’ phase of the observational study will see the Neonav clinical prototype be used to record intravascular ECG data from 50 patients undergoing umbilical venous catheter procedures.

The prototype has already shown some promising early results and is expected to detect some potential line migration which will contribute to patient safety.

“This is such an exciting milestone for our whole team because it’s the first time a device we have designed and built is being used on real patients,” says Mubin Yousef, Navi Founder & Chief Technology Officer.

“We are already starting to see a great interest from our colleagues in the device and we just initiated the next stage of our study. Everybody can see the positive impact this device will have and that’s a great feeling,” adds A/Prof Christiane Theda, Navi Founder & Chief Medical Officer.

Find out more about Navi and follow their journey at www.navitechnologies.com.